A multicenter phase l/ll study of obatoclax mesylate administered as a 3- Or 24-hour infusion in older patients with previously untreated acute myeloid leukemia
- Aaron D. Schimmer
- , Azra Raza
- , Thomas H. Carter
- , David Claxton
- , Harry Erba
- , Daniel J. DeAngelo
- , Martin S. Tallman
- , Carolyn Goard
- , Gautam Borthakur
Research output: Contribution to journal › Article › peer-review
77
Link opens in a new tab
Scopus
citations